| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.093 | 0.004 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.007 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.007 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.008 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.077 | 0.009 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.01 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.01 |